Literature DB >> 9447781

Quality control of Kato slide counts for Schistosoma mansoni: a review of 12 years' experience in Kenya.

R F Sturrock1, J H Ouma, H C Kariuki, F W Thiongo, D K Koech, A E Butterworth.   

Abstract

A total of 19 annual or biannual audits were performed over a 12-year period by an independent microscopist on randomized subsamples of Kato slides examined for Schistosoma mansoni eggs by Kenyan microscopists from the Division of Vector-borne Diseases (DVBD). The recounts were invariably lower than the originals owing to some deterioration of the preparations between counts, but the two were strongly correlated: significant regressions of recounts on counts taking up 80-90% of the observed variance. Observer bias differed significantly between microscopists but remained stable over time, whereas repeatability of recounts on counts dropped slightly in periods of maximum work load but did not vary systematically with time. Approximately 7% of the counts and recounts disagreed on the presence or absence of eggs, but less than a third of these were negatives that were found positive on recount. False negatives dropped to 1.3% if duplicate counts were considered. The performance of the Kenyan microscopists was remarkably high and consistent throughout the 12-year period. This form of quality control is suitable for projects where limited funds preclude full-time supervisors using more sophisticated systems.

Keywords:  Africa; Africa South Of The Sahara; Clinical Research; Developing Countries; Diseases; Eastern Africa; English Speaking Africa; Examinations And Diagnoses; Health; Kenya; Laboratory Examinations And Diagnoses; Organization And Administration; Parasite Control; Parasitic Diseases; Public Health; Quality Control; Research Methodology; Research Report

Mesh:

Year:  1997        PMID: 9447781      PMCID: PMC2487020     

Source DB:  PubMed          Journal:  Bull World Health Organ        ISSN: 0042-9686            Impact factor:   9.408


  7 in total

1.  Quality control in laboratory investigations on Schistosoma mansoni on St Lucia, West Indies: a staff assessment scheme.

Authors:  R K Bartholomew; M J Goddard
Journal:  Bull World Health Organ       Date:  1978       Impact factor: 9.408

2.  A simple device for quantitative stool thick-smear technique in Schistosomiasis mansoni.

Authors:  N Katz; A Chaves; J Pellegrino
Journal:  Rev Inst Med Trop Sao Paulo       Date:  1972 Nov-Dec       Impact factor: 1.846

3.  Quick Kato smear for field quantification of Schistosoma mansoni eggs.

Authors:  P A Peters; M El Alamy; K S Warren; A A Mahmoud
Journal:  Am J Trop Med Hyg       Date:  1980-03       Impact factor: 2.345

4.  Schistosoma mansoni in the baboon (Papio anubis): parasitological responses of Kenyan baboons to different exposures of a local parasite strain.

Authors:  R F Sturrock; A E Butterworth; V Houba
Journal:  Parasitology       Date:  1976-12       Impact factor: 3.234

5.  Quality control in laboratory investigations on Schistosoma mansoni in St. Lucia, West Indies. Maintenance of artificial prevalence as a laboratory aid.

Authors:  R K Bartholomew; P Jordan
Journal:  Bull World Health Organ       Date:  1978       Impact factor: 9.408

6.  Comparison of different chemotherapy strategies against Schistosoma mansoni in Machakos District, Kenya: effects on human infection and morbidity.

Authors:  A E Butterworth; R F Sturrock; J H Ouma; G G Mbugua; A J Fulford; H C Kariuki; D Koech
Journal:  Parasitology       Date:  1991-12       Impact factor: 3.234

7.  Immunity after treatment of human schistosomiasis mansoni. I. Study design, pretreatment observations and the results of treatment.

Authors:  A E Butterworth; P R Dalton; D W Dunne; M Mugambi; J H Ouma; B A Richardson; T K Siongok; R F Sturrock
Journal:  Trans R Soc Trop Med Hyg       Date:  1984       Impact factor: 2.184

  7 in total
  1 in total

1.  Parameters of the attenuated schistosome vaccine evaluated in the olive baboon.

Authors:  Thomas M Kariuki; Idle O Farah; Dorcas S Yole; Jason M Mwenda; Govert J Van Dam; André M Deelder; R Alan Wilson; Patricia S Coulson
Journal:  Infect Immun       Date:  2004-09       Impact factor: 3.441

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.